Pure Global
NCT03548740

Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection

Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection and Cervical Cytological Abnormalities.
Peking Union Medical College Hospital·ClinicalTrials.gov·biological
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Papillomavirus Infections
Drug/Device/Intervention
Human Papillomavirus
Study type
Observational
Intervention type
biological
Sponsor & location
Primary sponsor
Peking Union Medical College Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2018
End date
May 20, 2020
Enrollment
151 participants
Primary outcome

Vaginal microbiota and HR-HPV infection,Vaginal microbiota and the cervical lesion

Summary

Since other genital infections enhance HIV susceptibility by inducing inflammation, the
 investigators study the relationship between the vaginal microbiota composition and the risk
 of HPV infection, cervical cytological abnormalities.

ICD-10 classifications
Papillomavirus as the cause of diseases classified to other chaptersPapovavirus infection, unspecified sitePapilloedema, unspecifiedViral infection, unspecifiedParvovirus as the cause of diseases classified to other chapters
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03548740
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03548740 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking Union Medical College Hospital and is currently status unknown. The study focuses on Papillomavirus Infections. Target enrollment is 151 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.